Lee Frank D., a director at Bausch Health Companies Inc. ($BHC), sold shares once on the open market in the last 365 days for a total of $122,000. His most recent sale occurred on August 21, 2025. These sales rank 9,285th among 11,678 individual insiders in our database, where the average sale totals $8.6 million across about 6.4 transactions. Lee Frank D. made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | A | Common Stock | 261818 | $0.00 | 660,830.8410 | 45,729,000 | 65.62% | 0.57% |
| Jan. 30, 2026 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | F | Common Stock | 41488 | $20.54 | 399,012.8410 | 45,729,000 | 9.42% | 0.09% |
| Jan. 2, 2026 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | F | Common Stock | 9272 | $24.46 | 440,500.8410 | 45,729,000 | 2.06% | 0.02% |
| Aug. 21, 2025 | Bausch Health Companies Inc. | $BHC | Lee Frank D. | Director | S | Common Shares, No Par Value | 15912 | $7.66 | 73,795.0000 | 368,000,000 | 17.74% | 0.00% |
| May 16, 2025 | Bausch Health Companies Inc. | $BHC | Lee Frank D. | Director | A | Common Shares, No Par Value | 54347 | $0.00 | 89,707.0000 | 368,000,000 | 153.70% | 0.01% |
| Feb. 1, 2025 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | A | Common Stock | 350000 | $0.00 | 448,409.0000 | 46,245,000 | 355.66% | 0.76% |
| Jan. 2, 2025 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | F | Common Stock | 9375 | $18.33 | 98,409.0000 | 46,245,000 | 8.70% | 0.02% |
| Aug. 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | P | Common Stock | 8264 | $12.10 | 107,784.0000 | 51,979,000 | 8.30% | 0.02% |
| June 12, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Lee Frank D. | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2024 | Bausch Health Companies Inc. | $BHC | Lee Frank D. | Director | A | Common Shares, No Par Value | 35360 | $0.00 | 35,360.0000 | 364,900,000 | 9999.99% | 0.01% |
| Jan. 3, 2024 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | A | Stock Option (Right to Buy) | 692512 | $0.00 | 692,512.0000 | 51,979,000 | 9999.99% | 1.33% |
| Jan. 2, 2024 | Pacira BioSciences, Inc. | $PCRX | Lee Frank D. | Chief Executive Officer | A | Common Stock | 99520 | $0.00 | 99,520.0000 | 51,979,000 | 9999.99% | 0.19% |